There is a compelling value proposition for ophthalmologists and optometrists, patients, contact lens manufacturers, pharmaceutical companies and payers.
New Drug-eluting Contact Lens to Provide Timed Drug Delivery Directly to Eye; Improving Recovery, Reducing Cost for Millions after Eye Surgery and LASIK. OcuMedic.
Competitors and Competitive Advantage Currently topical eye drops, the standard of care controlling over 90% of the ocular pharmaceutics market, are inefficient and inconvenient as drops are washed from the eye in 30-45 minutes with substantial peaks and valleys in drug concentration.
New and Media New Contact Lens Technology to Deliver Drugs Directly to Eye; Improve Healing for Millions after Surgery and Lasik. The soft contact lenses, developed by biomedical researchers at Rowan University, are imprinted with anti-inflammatory…